Cargando…
Inflammasome signaling proteins as biomarkers of COVID-19
INTRODUCTION: One of the main characteristics of COVID-19 is an exacerbated inflammatory response that results in cardiometabolic complications and dysfunction in the nervous system. Moreover, these complications may extend beyond the period of active SARS-CoV2 infection and even extend over a year....
Autores principales: | Hadad, Roey, Keane, Robert W., de Rivero Vaccari, Juan Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165091/ https://www.ncbi.nlm.nih.gov/pubmed/37168848 http://dx.doi.org/10.3389/fimmu.2023.1014665 |
Ejemplares similares
-
The Inflammasome in Times of COVID-19
por: de Rivero Vaccari, Juan Carlos, et al.
Publicado: (2020) -
The Role of Non-canonical and Canonical Inflammasomes in Inflammaging
por: Cyr, Brianna, et al.
Publicado: (2022) -
The Inflammasome Signaling Proteins ASC and IL-18 as Biomarkers of Psoriasis
por: Forouzandeh, Mahtab, et al.
Publicado: (2020) -
Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018) -
Neural–Cardiac Inflammasome Axis after Traumatic Brain Injury
por: Keane, Robert W., et al.
Publicado: (2023)